Suvorexant S-Isomer | CAS 1030377-80-0 - Request Quote
Suvorexant S-Isomer
| SZ CAT No: | SZ-S052003 |
| CAS No | 1030377-80-0 |
| Mol.F. | C23H23ClN6O2 |
| Mol.Wt. | 450.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Suvorexant S-Isomer is chemically (S)-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone. Suvorexant S-Isomer is supplied with detailed characterization data compliant with regulatory guideline. Suvorexant S-Isomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Suvorexant.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1030377-80-0
Purchase 1030377-80-0
Order 1030377-80-0
Enquire 1030377-80-0
price of 1030377-80-0
1030377-80-0 Supplier
1030377-80-0 Manufacturer
1030377-80-0 Exporter
buy high quality Suvorexant S-Isomer
Purchase Suvorexant S-Isomer
Suvorexant S-Isomer suppliers
Suvorexant S-Isomer manufacturers
Suvorexant S-Isomer price
Order Suvorexant S-Isomer
Enquire Suvorexant S-Isomer
Suvorexant S-Isomer cost
Suvorexant S-Isomer Supplier
Suvorexant S-Isomer Distributor
Suvorexant S-Isomer for Method Validation
Suvorexant Reference Standard
Suvorexant S-Isomer for ANDA Filing
Suvorexant S-Isomer for Forced Degradation Studies
Suvorexant S-Isomer Identification Standards
Suvorexant S-Isomer for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.